165 related articles for article (PubMed ID: 37899170)
1. PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway.
Zhong J; Yuan C; Liu L; Du Y; Hui Y; Chen Z; Diao C; Yang R; Liu G; Liu X
Aging (Albany NY); 2023 Oct; 15(20):11654-11671. PubMed ID: 37899170
[TBL] [Abstract][Full Text] [Related]
2. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
Dong L; Li Y; Xue D; Liu Y
IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839
[TBL] [Abstract][Full Text] [Related]
3. Activation of the PI3K/Akt signal transduction pathway and increased levels of insulin receptor in protein repair-deficient mice.
Farrar C; Houser CR; Clarke S
Aging Cell; 2005 Feb; 4(1):1-12. PubMed ID: 15659208
[TBL] [Abstract][Full Text] [Related]
4. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
[TBL] [Abstract][Full Text] [Related]
5. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
6. PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer.
Liu J; Liu B; Li Y; Mi Z; Tan H; Rong P
Eur J Med Res; 2023 Aug; 28(1):289. PubMed ID: 37596654
[TBL] [Abstract][Full Text] [Related]
7. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
[TBL] [Abstract][Full Text] [Related]
8. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
9. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
[TBL] [Abstract][Full Text] [Related]
10. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
12. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.
Fan HT; Shi YY; Lin Y; Yang XP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7808-7815. PubMed ID: 31599405
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
[TBL] [Abstract][Full Text] [Related]
14. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
[TBL] [Abstract][Full Text] [Related]
16. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH
J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691
[TBL] [Abstract][Full Text] [Related]
18. Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway.
Yamaguchi K; Lee SH; Eling TE; Baek SJ
J Biol Chem; 2004 Nov; 279(48):49617-23. PubMed ID: 15377673
[TBL] [Abstract][Full Text] [Related]
19. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
[TBL] [Abstract][Full Text] [Related]
20. CDT1 facilitates metastasis in prostate cancer and correlates with cell cycle regulation.
Wang C; Che J; Jiang Y; Chen P; Bao G; Li C
Cancer Biomark; 2022; 34(3):459-469. PubMed ID: 35253732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
